Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 2, 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian CancerSören Weidemann, Natalia Gorbokon, Maximilian Lennartz, et al.
The Journal of Pathology. Clinical Research|August 7, 2021
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumorsViktor Reiswich, Natalia Gorbokon, Andreas M Luebke, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
Peerj|August 20, 2021
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressivenessKristina Jansen, Franziska Büscheck, Katharina Moeller, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
BMC Urology|February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosisHenning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Molecular Medicine (Cambridge, Mass.)|February 16, 2021
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumorsAnne Menz, Timo Weitbrecht, Natalia Gorbokon, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Pageof 25